Early detection may be your best chance for surviving lung cancer.
As reported in the landmark US National Lung Cancer Screening Trials study (NLST) published in the New England Journal of Medicine in July 2011, early detection enabled by low-dose CT scans resulted in a 20% reduction in lung cancer mortality.
Annual low-dose CT scanning (LDCT) is now an approved method of lung cancer screening in the US with associated reimbursement. BUT only if you meet the strict criteria published by the USPSTF guidelines4, derived from the National Lung Screening Trial (NLST): age 55-80, current or ex smoker (cessation within 15 years) and 30 pack year history.
As a simple blood test, EarlyCDT-Lung can be used when a patient is at increased risk of lung cancer but does not meet the criteria for annual CT screening. In addition, some patients are unwilling or unable to commit to annual CT scanning.
2 Howlader N, Noone AM, Krapcho M et al. SEER Cancer Statistics Review, 1975-2013, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/statfacts/html/lungb.html based on November 2015 SEER data submission, posted to the SEER web site, April 2016.
3 American Cancer Society, Cancer Facts & Figures 2015. Atlanta: American Cancer Society; 2015
How common is lung cancer in the USA?1
How common is lung cancer in Europe and the UK?1
How common is lung cancer in Asia?1
Electronic versions of the materials you are seeking to access are being made available on this website by Oncimmune Holdings plc (the “Company”).
These materials are not directed to nor are they intended for access by persons located or resident in the United States, Australia, Canada, South Africa, Japan or any other jurisdiction where to do so would constitute a violation of the relevant laws or regulations of such jurisdiction.
None of the securities of Company discussed or referred to in the materials you are seeking to access have been registered under the US Securities Act or 1933, as amended (the “Securities Act”) and may not be offered, sold, pledged or otherwise transferred except (1) in an offshore transaction meeting the requirements of Rule 903 or Rule 904 of Regulation S under the Securities Act, (2) pursuant to an effective registration statement under the Securities Act, or (3) pursuant to an available exemption from the registration requirements of the Securities Act, in each case in accordance with all applicable securities laws.
By clicking the “SUBMIT” button below you confirm that you (1) have read and understood the information set out above, (2) agree to be bound by its terms, (3) are not located in the United States and do not have a registered address in, and are not resident or located in, Australia, Canada, South Africa or Japan and (4) are permitted under applicable law and regulation to proceed to the following parts of this website.